History
  • No items yet
midpage
Aristo Vojdani v. Pharmasan Labs, Incorporated
741 F.3d 777
7th Cir.
2013
Read the full case

Background

  • Vojdani and Immunosciences signed a June 2007 letter of intent to supply testing plates; NeuroScience would pay invoices at 50% of client price.
  • The letter provided 180-day duration with an option to extend; payments were based on NeuroScience's monthly sales, and no past-due amounts were asserted.
  • After 180 days, NeuroScience ceased business, prompting Vojdani to sue in federal court for breach of contract (diversity jurisdiction).
  • First trial: verdict for NeuroScience on full payment; district court granted a partial new trial to address contract modification; second trial awarded Vojdani $187,000 based on modified-contract theory.
  • Second claim (confidentiality): NeuroScience used Vojdani’s testing methods after termination; jury awarded ~$1.165 million, but district court later vacated JMOL on damages, citing lack of a proper damages theory.
  • On appeal, the court affirmed, holding the new-trial grant and scope proper; damages for the confidentiality claim were not sustain-able under a reasonable royalty or other presented theory.
  • The court concluded Vojdani failed to present a damages theory (e.g., reasonable royalty) to support the confidentiality claim at trial.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the district court abused its discretion granting a partial new trial Vojdani argues the scope was too broad and misframes modification. NeuroScience contends the new-trial scope was appropriate to fix flawed verdicts. No abuse; district court acted within discretion.
Whether the contract-modification issue could be heard in the second trial Waiver under Rule 49(a)(3) prevented re-submission; modification not resolvable in second trial. District court properly allowed the modification issue given flawed first-trial verdict form. Courts allowed second-trial consideration of modification; no error.
Whether the damages award for breach of confidentiality was properly permissible Damages arise from continued use of confidential information; reasonable royalty or diverted-trade theories may apply. No evidence of sales loss; damages not supported by a presented theory. Damages not sustained; JMOL for NeuroScience affirmed.
Whether a reasonable royalty theory was available or properly presented Judgment could be based on reasonable royalty evidence from the expired letter of intent. No argument or instructions on reasonable royalty were presented at trial. Reasonable royalty theory not preserved; cannot support verdict.
Whether the district court correctly held that a new trial on the modification issue was proper Modification not properly raised; second trial should not revisit first verdict. Correcting flawed verdicts permits such scope. Affirmed; second-trial decision within district court’s discretion.

Key Cases Cited

  • Medcom Holding Co. v. Baxter Travenol Labs., Inc., 106 F.3d 1388 (7th Cir. 1997) (abuse-of-discretion standard for Rule 59(a) new trials; flawed verdict forms)
  • Mattson v. Schultz, 145 F.3d 937 (7th Cir. 1998) (ambiguity in special verdicts warrants reversal or new trial)
  • Burger v. Int'l Union of Elevator Constructors Local No. 2, 498 F.3d 750 (7th Cir. 2007) (flawed verdict forms may require new damages trial)
  • Fort Howard Paper Co. v. Standard Havens, Inc., 901 F.2d 1373 (7th Cir. 1990) (district court may excise confusing verdict questions on its own)
  • Pactiv Corp. v. Rupert, 724 F.3d 999 (7th Cir. 2013) (waivers may be excused to allow issues to be addressed with notice)
  • Rhone-Poulenc Rorer, Inc. v., 51 F.3d 1293 (7th Cir. 1995) (right to jury trial; issues decided by one jury should not be reconsidered absent errors warranting new trial)
  • Celeritas Technologies, Ltd. v. Rockwell Int’l Corp., 150 F.3d 1354 (Fed. Cir. 1998) (reasonable royalty as damages for breach of confidentiality)
  • Forest Labs., Inc. v. Pillsbury Co., 452 F.2d 621 (7th Cir. 1971) (standard for reasonable royalty and damages in confidential information cases)
  • U.S. Naval Inst. v. Charter Communications, Inc., 936 F.2d 692 (2d Cir. 1991) (loss measure considerations in damages; competition context)
Read the full case

Case Details

Case Name: Aristo Vojdani v. Pharmasan Labs, Incorporated
Court Name: Court of Appeals for the Seventh Circuit
Date Published: Dec 20, 2013
Citation: 741 F.3d 777
Docket Number: 13-1242, 13-1354
Court Abbreviation: 7th Cir.